- Home
- ELMD vs MIST Comparison
ELMD vs MIST Comparison
Compare ELMD & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | MIST |
|---|---|---|
| Founded | 1992 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.5M | 163.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELMD | MIST |
|---|---|---|
| Price | $28.02 | $2.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $36.00 | $6.33 |
| AVG Volume (30 Days) | 50.0K | ★ 3.4M |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.89 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $66,218,999.00 | N/A |
| Revenue This Year | $14.63 | N/A |
| Revenue Next Year | $11.54 | N/A |
| P/E Ratio | $29.53 | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $17.73 | $0.63 |
| 52 Week High | $35.56 | $2.77 |
Technical Indicators
Market Signals| Indicator | ELMD | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 63.93 | 70.83 |
| Support Level | $26.10 | $2.52 |
| Resistance Level | $27.94 | $2.75 |
| Average True Range (ATR) | 0.97 | 0.19 |
| MACD | 0.19 | 0.03 |
| Stochastic Oscillator | 83.77 | 86.54 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).